- Home
- CHRS vs TWIN Comparison
CHRS vs TWIN Comparison
Compare CHRS & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- TWIN
- Stock Information
- Founded
- CHRS 2010
- TWIN 1918
- Country
- CHRS United States
- TWIN United States
- Employees
- CHRS N/A
- TWIN N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- TWIN Industrial Machinery/Components
- Sector
- CHRS Health Care
- TWIN Industrials
- Exchange
- CHRS Nasdaq
- TWIN Nasdaq
- Market Cap
- CHRS 102.0M
- TWIN 97.0M
- IPO Year
- CHRS 2014
- TWIN N/A
- Fundamental
- Price
- CHRS $1.05
- TWIN $8.50
- Analyst Decision
- CHRS Buy
- TWIN Strong Buy
- Analyst Count
- CHRS 3
- TWIN 1
- Target Price
- CHRS $4.68
- TWIN $12.00
- AVG Volume (30 Days)
- CHRS 1.5M
- TWIN 32.7K
- Earning Date
- CHRS 08-07-2025
- TWIN 08-21-2025
- Dividend Yield
- CHRS N/A
- TWIN 1.88%
- EPS Growth
- CHRS N/A
- TWIN N/A
- EPS
- CHRS 1.55
- TWIN 0.29
- Revenue
- CHRS $272,209,000.00
- TWIN $328,478,000.00
- Revenue This Year
- CHRS N/A
- TWIN $17.34
- Revenue Next Year
- CHRS $142.61
- TWIN $9.01
- P/E Ratio
- CHRS $2.05
- TWIN $29.18
- Revenue Growth
- CHRS 52.33
- TWIN 11.49
- 52 Week Low
- CHRS $0.66
- TWIN $6.16
- 52 Week High
- CHRS $2.43
- TWIN $13.40
- Technical
- Relative Strength Index (RSI)
- CHRS 62.88
- TWIN 40.15
- Support Level
- CHRS $0.81
- TWIN $8.41
- Resistance Level
- CHRS $0.95
- TWIN $9.05
- Average True Range (ATR)
- CHRS 0.07
- TWIN 0.33
- MACD
- CHRS 0.01
- TWIN -0.04
- Stochastic Oscillator
- CHRS 85.71
- TWIN 39.83
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.